Stemline Therapeutics Inc asset turnover ratio, the ability of Stemline Therapeutics Inc's assets to generate revenue in the first quarter 2020, increased sequentially to 0.28 in the first quarter (Mar 31 2020), yet the ratio remained below the average, as STML's position remain challenging.

Within sector 182 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the First Quarter 2020 compared to the preceding quarter from 3343 to 3363.

Asset Turnover Ratio Definition

Select the Comparisons :

None ▼

Select the Ratio:

Asset Turnover▼

None ▼

Asset Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

STML Asset Turnover Ratio	(Mar 31 2020) I. Quarter	(Dec 31 2019) IV. Quarter	(Sep 30 2019) III. Quarter	(Jun 30 2019) II. Quarter	(Mar 31 2019) I. Quarter
Y / Y Asset Change	25.04 %	194.49 %	144.76 %	28.52 %	26.46 %
Y / Y Revenue Change	75.74 %	5796.71 %	-	2501.34 %	-
Asset Turnover Ratio (TTM)	0.28	0.27	0.24	0.18	0.06
STML's Total Ranking	# 3363	# 3343	# 3210	# 0	# 2731
Seq. Asset Change	-8.94 %	-5.65 %	54.64 %	-5.89 %	114.46 %
Seq. Revenue Change	-24.99 %	-11.28 %	2.51 %	157.63 %	2416.71 %

Asset Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 183
Healthcare Sector	# 468
Overall Market	# 3363

Asset Turnover Ratio Statistics
High	Average	Low
6.72	4.15	3.21
(Dec 31 2014)		(Mar 31 2020)

STML Company Profile • Back to STML Efficiency Comparisons • Compare STML Asset Turnover Ratio to its Competitors

Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2020, within Healthcare Sector	Asset Turnover Ratio	Revenues for 12 Months ending Mar 31 2020	Assets at quarter ending Mar 31 2020
Biomerica Inc	0.75	$ 5.134 Millions	$ 6.806 Millions
Dr Reddy s Laboratories Limited	0.75	$ 2,316.000 Millions	$ 3,081.000 Millions
3m Company	0.75	$ 32,348.000 Millions	$ 43,097.500 Millions
Cryo cell International Inc	0.75	$ 31.942 Millions	$ 42.583 Millions
Pressure Biosciences Inc	0.75	$ 1.554 Millions	$ 2.073 Millions
Alphatec Holdings Inc	0.75	$ 118.987 Millions	$ 158.876 Millions
Icu Medical Inc	0.75	$ 1,263.883 Millions	$ 1,692.516 Millions
Intersect Ent Inc	0.75	$ 102.295 Millions	$ 137.038 Millions
Edwards Lifesciences Corporation	0.74	$ 4,483.700 Millions	$ 6,026.000 Millions
Elite Pharmaceuticals Inc	0.74	$ 17.995 Millions	$ 24.215 Millions
Stereotaxis Inc	0.74	$ 27.649 Millions	$ 37.412 Millions
Imac Holdings Inc	0.74	$ 15.678 Millions	$ 21.237 Millions
American Renal Associates Holdings Inc	0.74	$ 823.942 Millions	$ 1,119.051 Millions
Incyte Corporation	0.72	$ 2,229.409 Millions	$ 3,085.406 Millions
Biodelivery Sciences International Inc	0.72	$ 129.898 Millions	$ 179.804 Millions
Neurocrine Biosciences Inc	0.72	$ 886.784 Millions	$ 1,228.684 Millions
Abiomed Inc	0.72	$ 840.883 Millions	$ 1,165.620 Millions
Masimo Corp	0.72	$ 975.798 Millions	$ 1,353.683 Millions
Rennova Health Inc	0.72	$ 11.519 Millions	$ 15.994 Millions
Veru Inc	0.72	$ 38.977 Millions	$ 54.244 Millions
Neos Therapeutics Inc	0.71	$ 64.508 Millions	$ 90.245 Millions
Invo Fertility Inc	0.71	$ 1.549 Millions	$ 2.179 Millions
Radnet Inc	0.71	$ 1,164.193 Millions	$ 1,640.239 Millions
Axogen inc	0.71	$ 107.688 Millions	$ 152.580 Millions
Tivity Health Inc	0.71	$ 1,254.718 Millions	$ 1,778.800 Millions
Mannkind Corporation	0.70	$ 61.825 Millions	$ 87.718 Millions
Dexcom Inc	0.70	$ 1,600.600 Millions	$ 2,273.625 Millions
Societal Cdmo Inc	0.70	$ 95.931 Millions	$ 136.731 Millions
Pacific Health Care Organization Inc	0.70	$ 7.100 Millions	$ 10.153 Millions
Natera Inc	0.69	$ 329.516 Millions	$ 476.218 Millions

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.